EU authorities agree new measures to support availability of medicines used in the COVID-19 pandemic

The continued availability of medicines, in particular those used for patients with COVID-19, is of critical concern for EMA and its partners in the European medicines regulatory network in light of the medical emergency presented by the pandemic.

source https://www.pharmatutor.org/pharma-news/2020/eu-authorities-agree-new-measures-to-support-availability-of-medicines-used-in-the-covid-19-pandemic